Advisory body faces critics on drug payments
Advisory body faces critics on drug payments
The government's medicines advisory body meets critics today to debate changes to the way it decides whether the National Health Service pays for costly new drugs.
The Financial Times
Content for class "clearing" Goes Here
 |
 |
Content for class "clearing" Goes Here